Incyte Corp.
NASDAQ:INCY 3:32:11 PM EDT
| Market Cap (Intraday) | 13.77B |
| Current PE | 42.44 |
| Forward PE | 22.86 |
| 2yr Forward PE | 15.58 |
| 10-Day MA | $62.63 |
| 50-Day MA | $68.94 |
| 200-Day MA | $74.27 |
Incyte Corp. Stock, NASDAQ:INCY
1801 Augustine Cut-Off, 1801 Augustine Cut-Off, Wilmington, Delaware 19803
United States of America
Phone: +1.302.498.6700
Number of Employees: 2324
Description
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company was founded in April 1991 and is headquartered in Wilmington, DE.